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changes in knee OA symptoms and function that occur with 
weight loss. 
Methods: Data are drawn from a larger study evaluating the ef- 
fects of weight loss in overweight and obese adults with knee OA. 
All participants met ACR criteria for knee OA, were K-L grade 2-  
3, reported pain on _> 50% of days each month in one or both 
knees and difficulty with daily activities. Pain, stiffness and func- 
tion were assessed at baseline and after 16 week weight loss 
program using WOMAC. Fasting serum samples at baseline and 
week 16 were assayed for IL-1, IL-6, and TNF-~ using multiplex 
kits (Linco Research, Inc). 
Results: Participants were (mean 4- SD) 57.0 4- 6.17 years, 
mostly white (93%), female (81.5%) and used anti-inflammatory 
medications (63%). Baseline weight was 90.6 4- 9.1 kg and 106.7 
4- 11.8 kg for women and men respectively. IL-1, IL-6 and TNF-~ 
were detectable at baseline in 48%, 28%, and 28% of the sam- 
ple, respectively. Women lost 6.14- 4.6 kg and men lost 10.4 4- 
5.5 kg. Weight loss was associated with significant (p's < 0.001) 
improvements in pain (46.2%), stiffness (49.9%) and function 
(51.9%) with no differences by gender. Higher levels of serum 
cytokines at baseline were predictive of less improvement in pain 
and function after adjustment for weight loss, age, gender and 
medications. Similar trends were found for TNF-~. Baseline cy- 
tokine concentrations were not associated with change in stiff- 
ness; cytokine levels were not associated with anti-inflammatory 
use at either time point. 
Crude and adjusted correlations between baseline serum cytokines and 
changes in pain and function in response to weight loss 
Pain Function 
Crude Model 1 Model 2 Crude Model 1 Model 2 
ILl -.420** -.474** -.550** -.298* -.552** -.614"* 
IL6 -.398* -.517"* -.503** -.230 -.407* -.413" 
TNF-a -.318 -.491"* -.474** -.145 -.334~ -.344~ 
*p<.05; **p<.01 ; ~p<.10. Model 1 : Adjusted for age, gender, baseline value. 
Model 2: Adjusted for age, gender, baseline value and weight change. 
Conclusions: Serum IL-1, IL-6 and TNF-~ concentrations are 
detectable in some overweight and obese persons with disabling 
symptomatic knee OA, and predict smaller reductions in pain and 
function to a weight loss intervention, independent of amount of 
weight lost. 
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Introduction: Tegner activity levels are frequently reported in as- 
sessing outcomes of arthroscopic knee surgery. Average Teg- 
ner scores may be misleading if the cohort of study subjects 
has widely varied activity levels prior to the index injury. Conse- 
quently, we have formulated a "Tegner Index" that calculates the 
percentage of the pre-injury activity level that is regained by the 
patient after surgical intervention. Thus, the Tegner Index normal- 
izes study results by more accurately considering each patient's 
response to therapy. The purpose of this study was to assess 
effectiveness of treatment of the knee meniscus on return to ac- 
tivity, as determined by the Tegner Index, in patients in a random- 
ized clinical trial of the Collagen Meniscus Implant (CMI). 
Methods: Patients between 18 and 60 years of age who had 
undergone one to three prior partial medial meniscectomies and 
currently continued to have clinical symptoms of meniscus pathol- 
ogy were randomized either to receive the CMI or to have an 
additional partial medial meniscectomy (control). Twenty consec- 
utive patients who met all inclusion criteria and had a minimum 
2-year follow-up had the Tegner Index calculated. There were 12 
CMI and 8 control patients. Tegner Index was calculated by sub- 
tracting the preoperative Tegner score from the 2-year score and 
dividing that difference by the difference of the pre-injury score 
less the preoperative score. The quotient is multiplied by 100 to 
obtain a percentage that represents the amount of lost activity 
that has been regained as a result of the intervention. 
Results: The average Tegner Index for the CMI patients was 
0.60; hence, two years after receiving the CMI those patients had 
regained 60% of the activity that they had lost as a result of their 
inciting injury. The control patients had an average Tegner Index 
of (negative) -0.18; thus, over the two year follow-up those pa- 
tients had continued to decrease their activity levels. This differ- 
ence was statistically significant (p=0.031) using an independent 
t-test. 
Conclusion: The Tegner Index provides the surgeon with a more 
meaningful method of assessing success of treatment based on 
the percentage of return of activity rather than looking at only the 
raw Tegner score. We found that patients who received the CMI 
for treatment of meniscus pathology had a significantly higher 
Tegner Index at two years compared to controls. 
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Aim: In this study, we defined and compared the expression of 
TG2 and FXlIIA throughout he course of spontaneous knee OA 
Hartley guinea pigs. We tested the hypothesis that TG2 serves 
as a biomarker for both early OA development in the medial tibial 
plateau and for OA progression. 
Methods: Male Hartley guinea pigs were obtained at two months 
of age and sacrificed at 2, 4, 7, 10, 12 and 18 months of age 
(n=6 in each group). One knee joint was prepared for histologi- 
cal grading and cartilage was collected from both the medial and 
lateral compartments of the other knee joint for the production of 
cDNA. Synovial fluid was collected from both knees and pooled 
for analyses. A semi-quantitative histological grading system was 
used to evaluate OA severity. ELISA was used to quantify lev- 
els found in synovial fluid of the two cartilage-associated TGs, 
TG2 and FXlIIA, in addition to cartilage oligomeric matrix protein 
(COMP). Real-time PCR was used to quantify the expression lev- 
els of TG2 and FXlIIA from both medial and lateral compartments. 
Data were analyzed by ANOVA followed by Tukey's multiple com- 
parison test, and linear regression performed. Multiple regression 
modeling was used to evaluate the association of these biomark- 
ers with histological OA severity, with p-value < 0.05 considered 
significant. 
Results: Steady-state mRNA expression of TG2 in guinea pig 
cartilage was detectable at low levels in the lateral compartment 
and increased progressively from 4 to 18 months of age in the 
tibial plateau medial compartment, the site of earliest and most 
severe OA degeneration. From 2 to 18 months of age, the mean 
cartilage TG2 m RNA expression was significantly correlated with 
$40 Poster Presentat ions 
the mean total histological score, as well as with medial com- 
partment score (p=0.028, r=0.859 and p=0.033, r=0.847, respec- 
tively). Steady-state mRNA levels of FXlIIA were not detectable 
in either the medial or the lateral compartment until 12 months 
of age, when a low level of expression was detected in the me- 
dial compartment. Concentrations of TG2 in guinea pig synovial 
fluid rose steadily from 7 to 12 months of age and correlated 
significantly with total histological score (p=0.03, r=0.46). TG2 
concentrations also correlated strongly with synovial fluid COMP 
(p=0.05, r=0.39). The association of TG2 with histological out- 
come remained significant after adjusting for the effects of age, 
weight, and COMP. There was no significant change in the levels 
of SF FXlIIA with age, as well as no correlation with total histo- 
logical score. 
Conclusions: Our results reveal that TG2, but not FXlIIA mRNA 
expression and synovial fluid protein concentrations, reflect his- 
tological OA in the guinea pig model as well as disease pro- 
gression. These findings are consistent with the proposed role 
of TG2 in OA pathogenesis via effects on chondrocyte differenti- 
ation. TG2, expressed by chondrocytes in situ and released into 
the synovial fluid, also serves as a novel and TG family-specific 
biomarker of OA development and progression. 
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The aim of this study was to measure hyaluronic acid (HA) 
turnover in the synovial fluid of normal and degenerate knee joints 
using a novel in vivo labeling method. 
Newly-synthesized HA was labeled in experimental animals by 
administering water enriched with 2H20 , first as an IP injection, 
then as drinking water. Following 24 hours of labeling, synovial 
fluid was collected from the knee joints by lavage, and the HA was 
isolated and analyzed by gas chromatography mass spectrome- 
try. The fraction of synovial fluid HA that was newly-synthesized 
was determined from the incorporation of 2H into N-acetyl glu- 
cosamine. Three animal models of osteoarthritis (OA) were used. 
Guinea pigs were analyzed both at a young age (2 months old) 
and after the onset of spontaneous OA (12 months old). Also, 
experimental OA was induced in one knee of rats by either a sin- 
gle intra-articular injection of the glycolysis inhibitor, monoiodoac- 
etate, or by meniscal tear surgery. Rats were analyzed five days 
after treatment, at which point, degenerative changes could be 
observed histologically. Contralateral knees were used as con- 
trols. 
In all cases, the fractional synthesis of synovial fluid HA was 
higher in aged or treated joints (Fig. 1). 724-8% of synovial fluid 
HA was turned over during the 24 hour labeling period in young 
guinea pigs, whereas older guinea pigs had a fractional synthe- 
sis of 874-7% (n=5-6, p<0.01 ). Monoiodoacetate (MIA) treatment 
led to an 16% increase in the fractional synthesis of the HA in 
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Fig. 1. Effect of experimentally induced OA on fractional synthesis of HA in 
the synovial fluid of the degenerate knee joint. 
the synovial fluid (n=3, p<0.01). Similarly, knees subjected to 
meniscal tear surgery (MNX) exhibited a fractional synthesis of 
HA of 704-1.3%, compared to control knees which had a frac- 
tional synthesis of 564-1.6% (n=2), although the differences were 
not statisically significant (p=0.1). 
The results of this study suggest a correlation between the os- 
teoarthritic hanges induced in these animal models and an in- 
crease in the turnover of the hyaluronan component of the syn- 
ovial fluid in the affected joint. Such an increase in HA may be 
due, in part, to the onset of synovitis, a common feature of os- 
teoarthritis. Indeed, our results may support clinical observations 
that synovitis correlates with OA progression. Since this method 
requires only a representative sampling of synovial fluid, it could 
provide a minimally invasive index of disease progression in hu- 
mans. 
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Aim of Study: Osteoarthritis (OA) is a degenerative joint disease 
characterized by progressive erosion of articular cartilage. Aggre- 
can is an important component of the extracellular matrix and so 
the monitoring of its degradation and formation could be useful in 
monitoring disease activity or the efficacy of treatment with chon- 
droprotective agents. The aim of the present study was to inves- 
tigate the potential of two newly developed immunoassays for the 
assessment of aggrecan metabolism under various experimental 
conditions. 
Methods: Ex vivo cartilage explants were cultured under serum- 
free conditions with either 1) no cytokines, 2) with the cy- 
tokines oncostatin M (OSM) and TNF~, or 3) with the aforemen- 
tioned cytokines plus an MMP-inhibitor, GM6001 101~M. For refer- 
ence purposes, metabolically inactivated cartilage explants were 
also included. The culture medium was replaced every 2nd-3  rd 
day, and assessed for changes in aggrecan metabolism. Aggre- 
can turnover was characterized by two independently developed 
sandwich immuno-assays: 1) Assay G2 employs a monoclonal 
antibody (F78) specific for the G2 domain of aggrecan, 2) Assay 
FFGVG-G2 combining the F78 antibody with a monoclonal anti- 
body (AF28) targeting the epitope 342FFGVG, which is generated 
during MMP digestion at the cleavage site VDIPEN-FFGVG in the 
interglobular domain of aggrecan. 
Results: Ex vivo cartilage explants were exposed to OSM and 
TNF-~ to induce cartilage degradation, which was accompanied 
by a gradual increase in the concentration of FFGVG-G2 from 
day Day 12 (Fig. 1). When the exposure of explants occurred in 
the concomitant presence of GM6001, the release of FFGVG-G2 
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